MRM Health and Biocodex establish strategic partnership to strengthen future commercial supply capabilities for CORAL®-based medicines

GHENT, Belgium, Nov 6 (Bernama) -- MRM Health and Biocodex establish strategic partnership to strengthen future commercial supply capabilities for CORAL®-based medicines

Collaboration combines MRM Health’s cutting-edge microbiome science and proprietary CORAL® platform with Biocodex’s industrialization and manufacturing capabilities

Planned €15 million investment by Biocodex in specialized anaerobic manufacturing infrastructure will establish an additional pathway for MH002 and other MRM Health programs, from clinical development toward potential commercial supply